Page last updated: 2024-08-24

dexfenfluramine and Fibrosis

dexfenfluramine has been researched along with Fibrosis in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Bruneval, P; Ennezat, PV; Malergue, MC; Ohanessian, A; Zannis, K	1
Bhattacharyya, S; Davar, J; Mikhailidis, DP; Schapira, AH	1
Arlt, VM; De Prez, E; Debelle, F; Deschodt-Lanckman, M; Nortier, J; Phillips, DH; Salmon, I; Vanherweghem, JL; Vienne, A	1

Reviews

1 review(s) available for dexfenfluramine and Fibrosis

Article	Year
Drug-induced fibrotic valvular heart disease. Lancet (London, England), 2009, Aug-15, Volume: 374, Issue:9689 Topics: Antiparkinson Agents; Appetite Depressants; Cabergoline; Dexfenfluramine; Dopamine Agonists; Drug Monitoring; Ergolines; Ergotamine; Fenfluramine; Fibrosis; Heart Valve Diseases; Heart Valves; Humans; Methysergide; Migraine Disorders; N-Methyl-3,4-methylenedioxyamphetamine; Patient Selection; Pergolide; Receptors, Serotonin; Serotonin Agents; Serotonin Plasma Membrane Transport Proteins; Vasoconstrictor Agents	2009

Article

Year

Drug-induced fibrotic valvular heart disease.

Lancet (London, England), 2009, Aug-15, Volume: 374, Issue:9689

Topics: Antiparkinson Agents; Appetite Depressants; Cabergoline; Dexfenfluramine; Dopamine Agonists; Drug Monitoring; Ergolines; Ergotamine; Fenfluramine; Fibrosis; Heart Valve Diseases; Heart Valves; Humans; Methysergide; Migraine Disorders; N-Methyl-3,4-methylenedioxyamphetamine; Patient Selection; Pergolide; Receptors, Serotonin; Serotonin Agents; Serotonin Plasma Membrane Transport Proteins; Vasoconstrictor Agents

2009

Other Studies

2 other study(ies) available for dexfenfluramine and Fibrosis

Article	Year
Dexfenfluramin: a forgotten cause of aortic stenosis. Acta cardiologica, 2020, Volume: 75, Issue:3 Topics: Aortic Valve Stenosis; Appetite Depressants; Chemically-Induced Disorders; Dexfenfluramine; Echocardiography, Doppler; Endocardium; Exercise Test; Female; Fibrosis; Heart Valve Diseases; Heart Valve Prosthesis Implantation; Humans; Middle Aged; Obesity; Tomography, X-Ray Computed	2020
Effects of dexfenfluramine on aristolochic acid nephrotoxicity in a rat model for Chinese-herb nephropathy. Archives of toxicology, 2003, Volume: 77, Issue:4 Topics: Animals; Aristolochic Acids; Autoradiography; Body Weight; Creatinine; Dexfenfluramine; Disease Models, Animal; DNA Adducts; Drug Synergism; Drugs, Chinese Herbal; Fibrosis; Injections, Subcutaneous; Kidney; Liver; Longevity; Male; Mutagens; Nephritis, Interstitial; Phosphorus Radioisotopes; Rats; Rats, Wistar; Serotonin Receptor Agonists	2003

Article

Year

Dexfenfluramin: a forgotten cause of aortic stenosis.

Acta cardiologica, 2020, Volume: 75, Issue:3

Topics: Aortic Valve Stenosis; Appetite Depressants; Chemically-Induced Disorders; Dexfenfluramine; Echocardiography, Doppler; Endocardium; Exercise Test; Female; Fibrosis; Heart Valve Diseases; Heart Valve Prosthesis Implantation; Humans; Middle Aged; Obesity; Tomography, X-Ray Computed

2020

Effects of dexfenfluramine on aristolochic acid nephrotoxicity in a rat model for Chinese-herb nephropathy.

Archives of toxicology, 2003, Volume: 77, Issue:4

Topics: Animals; Aristolochic Acids; Autoradiography; Body Weight; Creatinine; Dexfenfluramine; Disease Models, Animal; DNA Adducts; Drug Synergism; Drugs, Chinese Herbal; Fibrosis; Injections, Subcutaneous; Kidney; Liver; Longevity; Male; Mutagens; Nephritis, Interstitial; Phosphorus Radioisotopes; Rats; Rats, Wistar; Serotonin Receptor Agonists

2003